Company: CI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001739940-25-000009
Chunk: 127

Company: Cigna Group
Filing Date: 2025-02-27
Form: 10-K
Item: Item 4
Chunk 127
---
a Group, together with its subsidiaries (either individually or collectively referred to as the "Company," "we," "us" or "our"), is a global health company committed to creating a better future for every individual and every community. Our subsidiaries offer a differentiated set of pharmacy, medical, behavioral, dental, and related products and services. For further information on our business and strategy, see Part I, Item 1 "Business" of this Form 10-K. 

38

Financial Highlights

Consolidated Results of Operations (GAAP basis)For the Years Ended December 31,ChangeChange(Dollars in millions)2024202320222024 vs. 20232023 vs. 2022Pharmacy revenues$185,362 $137,243 $128,566 $48,119 35 %$8,677 7 %Premiums45,996 44,237 39,916 1,759 4 4,321 11 Fees and other revenues14,790 12,619 10,881 2,171 17 1,738 16 Net investment income973 1,166 1,155 (193)(17)11 1 Total revenues247,121 195,265 180,518 51,856 27 14,747 8 Pharmacy and other service costs182,509 133,801 124,834 48,708 36 8,967 7 Medical costs and other benefit expenses38,648 36,287 32,184 2,361 7 4,103 13 Selling, general and administrative expenses14,844 14,822 13,174 22 — 1,648 13 Amortization of acquired intangible assets1,703 1,819 1,876 (116)(6)(57)(3)Total benefits and expenses237,704 186,729 172,068 50,975 27 14,661 9 Income from operations9,417 8,536 8,450 881 10 86 1 Interest expense and other(1,435)(1,446)(1,228)11 (1)(218)18 Net gain (loss) on sale of businesses24 (1,499)1,662 1,523 N/M(3,161)N/MNet investment losses